A phase I clinical trial of intrahepatic artery delivery of TG6002 in combination with oral 5-fluorocytosine in patients with liver-dominant metastatic colorectal cancer

This is a preprint and may not have undergone formal peer review

West, E.J. orcid.org/0000-0001-7449-120X, Sadoun, A., Bendjama, K. et al. (21 more authors) (2024) A phase I clinical trial of intrahepatic artery delivery of TG6002 in combination with oral 5-fluorocytosine in patients with liver-dominant metastatic colorectal cancer. [Preprint - medRxiv]

Abstract

Metadata

Item Type: Preprint
Authors/Creators:
Dates:
  • Published: 31 July 2024
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Medical Research (LIMR) > Division of Haematology and Immunology
Depositing User: Symplectic Publications
Date Deposited: 28 Oct 2024 10:24
Last Modified: 28 Oct 2024 10:24
Identification Number: 10.1101/2024.07.30.24311046
Open Archives Initiative ID (OAI ID):

Export

Statistics